These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12061549)

  • 1. Identifying protein kinase inhibitors using an assay based on inhibition of aerial hyphae formation in Streptomyces.
    Waters B; Saxena G; Wanggui Y; Kau D; Wrigley S; Stokes R; Davies J
    J Antibiot (Tokyo); 2002 Apr; 55(4):407-16. PubMed ID: 12061549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of Microbial Extracts for Anticancer Compounds Using Streptomyces Kinase Inhibitor Assay.
    Shanbhag P; Bhave S; Vartak A; Kulkarni-Almeida A; Mahajan G; Villanueva I; Davies J
    Nat Prod Commun; 2015 Jul; 10(7):1287-91. PubMed ID: 26411032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic Sansanmycin Analogues as Potent
    Tran W; Kusay AS; Hawkins PME; Cheung CY; Nagalingam G; Pujari V; Ford DJ; Stoye A; Ochoa JL; Audette RE; Hortle E; Oehlers SH; Charman SA; Linington RG; Rubin EJ; Dowson CG; Roper DI; Crick DC; Balle T; Cook GM; Britton WJ; Payne RJ
    J Med Chem; 2021 Dec; 64(23):17326-17345. PubMed ID: 34845906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lapstatin, a new aminopeptidase inhibitor produced by Streptomyces rimosus, inhibits autogenous aminopeptidases.
    Repic Lampret B; Kidric J; Kralj B; Vitale L; Pokorny M; Renko M
    Arch Microbiol; 1999; 171(6):397-404. PubMed ID: 10369895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phebestin, a new inhibitor of aminopeptidase N, produced by Streptomyces sp. MJ716-m3.
    Nagai M; Kojima F; Naganawa H; Hamada M; Aoyagi T; Takeuchi T
    J Antibiot (Tokyo); 1997 Jan; 50(1):82-4. PubMed ID: 9066770
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel drug discovery concept for tuberculosis: inhibition of bacterial and host cell signalling.
    Székely R; Wáczek F; Szabadkai I; Németh G; Hegymegi-Barakonyi B; Eros D; Szokol B; Pató J; Hafenbradl D; Satchell J; Saint-Joanis B; Cole ST; Orfi L; Klebl BM; Kéri G
    Immunol Lett; 2008 Mar; 116(2):225-31. PubMed ID: 18258308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Streptomyces chromofuscus phospholipase D by antifungal lipopeptides from Bacillus subtilis.
    El Kirat K; Volpon L; Roux B; Besson F
    J Antibiot (Tokyo); 2004 Aug; 57(8):535-6. PubMed ID: 15515892
    [No Abstract]   [Full Text] [Related]  

  • 8. The antimicrobial activity of protein elicitor AMEP412 against Streptomyces scabiei.
    Liu Q; Shen Y; Yin K
    World J Microbiol Biotechnol; 2020 Jan; 36(1):18. PubMed ID: 31912374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TMC-89A and B, new proteasome inhibitors from streptomyces sp. TC 1087.
    Koguchi Y; Nishio M; Suzuki S; Takahashi K; Ohnuki T; Komatsubara S
    J Antibiot (Tokyo); 2000 Sep; 53(9):967-72. PubMed ID: 11099231
    [No Abstract]   [Full Text] [Related]  

  • 10. SNA-60-367, new peptide enzyme inhibitors against aromatase.
    Kimura K; Nakayama S; Nakamura J; Takada T; Yoshihama M; Esumi Y; Itoh Y; Uramoto M
    J Antibiot (Tokyo); 1997 Jun; 50(6):529-31. PubMed ID: 9268012
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclic lipodepsipeptides: time for a concerted action to unlock their application potential?
    Geudens N; Sinnaeve D; Martins JC
    Future Med Chem; 2018 Mar; 10(5):479-481. PubMed ID: 29411995
    [No Abstract]   [Full Text] [Related]  

  • 12. Deprogrammed sporulation in Streptomyces.
    Ohnishi Y; Seo JW; Horinouchi S
    FEMS Microbiol Lett; 2002 Oct; 216(1):1-7. PubMed ID: 12423744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of antifungal lipopeptides by reversed-phase high-performance liquid chromatography.
    Razafindralambo H; Paquot M; Hbid C; Jacques P; Destain J; Thonart P
    J Chromatogr; 1993 Jun; 639(1):81-5. PubMed ID: 8331146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Andrographolide: A potent antituberculosis compound that targets Aminoglycoside 2'-N-acetyltransferase in Mycobacterium tuberculosis.
    Prabu A; Hassan S; Prabuseenivasan ; Shainaba AS; Hanna LE; Kumar V
    J Mol Graph Model; 2015 Sep; 61():133-40. PubMed ID: 26245695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of sporulation, glycopeptide antibiotic production and resistance in Streptomyces toyocaensis NRRL 15009 by protein kinase inhibitors.
    Neu JM; Wright GD
    FEMS Microbiol Lett; 2001 May; 199(1):15-20. PubMed ID: 11356561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coproduction of surfactin and iturin A, lipopeptides with surfactant and antifungal properties, by Bacillus subtilis.
    Sandrin C; Peypoux F; Michel G
    Biotechnol Appl Biochem; 1990 Aug; 12(4):370-5. PubMed ID: 2119191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR-387A and B, new aminopeptidase N inhibitors, produced by Streptomyces neyagawaensis SL-387.
    Chung MC; Chun HK; Han KH; Lee HJ; Lee CH; Kho YH
    J Antibiot (Tokyo); 1996 Jan; 49(1):99-102. PubMed ID: 8609096
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic peptides of the nocardamine class from a marine-derived bacterium of the genus Streptomyces.
    Lee HS; Shin HJ; Jang KH; Kim TS; Oh KB; Shin J
    J Nat Prod; 2005 Apr; 68(4):623-5. PubMed ID: 15844966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NRPS substrate promiscuity leads to more potent antitubercular sansanmycin analogues.
    Xie Y; Cai Q; Ren H; Wang L; Xu H; Hong B; Wu L; Chen R
    J Nat Prod; 2014 Jul; 77(7):1744-8. PubMed ID: 24964393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.